KCM
AKTX

Knoll Capital Management’s Akari Therapeutics AKTX Stock Holding History

Knoll Capital Management’s Portfolio AKTX Stock Details AKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2
Closed -$78K – 16
2014
Q2 		$78K Sell
2
-1
-33% -$45.8K 0.03% 14
2014
Q1 		$151K Buy
+3
New +$170K 0.08% 14

Other funds holding AKTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Knoll Capital Management's AKTX Position: Q3 2014 in Review

Knoll Capital Management sold out of Akari Therapeutics (AKTX) in Q3 2014, closing a stake of 2 shares — an estimated $78K sold.

Knoll Capital Management first reported a position in AKTX in Q1 2014 and held it in 2 quarters. The position peaked at $151K in Q1 2014. 7 funds tracked by Wall St. Rank hold AKTX as of Q3 2014.

  • Knoll Capital Management reported no remaining Akari Therapeutics position as of Q3 2014 after selling out during the quarter.
  • Knoll Capital Management sold 2 Akari Therapeutics shares in Q3 2014, an estimated $78K.
  • Knoll Capital Management first reported a position in Akari Therapeutics in Q1 2014 and held it in 2 quarters.
  • Knoll Capital Management's Akari Therapeutics position peaked at $151K in Q1 2014.
  • 7 funds tracked by Wall St. Rank held Akari Therapeutics as of Q3 2014.

Based on Knoll Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.